Although our ELP-based polymers can target only IL-4R overexpressed cancer cells, many tumor of different origin have been reported to highly expressed IL-4R [19]–[22] and thus our designed polymer can be used as a potent drug carrier for various targeted cancer therapies. This evidence concerns the gene IL4R and neoplasm.